Lung
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Emerging Molecular Targets in Thymic Epithelial Tumors
FEATURING
Anja Roden
- 8 views
- September 26, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Current and Future Use of EGFR-Targeted Agents in Lung Cancer
FEATURING
Pilar Garrido
- 2 views
- September 26, 2024
2024 ESMO Annual Meeting Insights Hub
Management of Oligoprogressive Disease: Patients With Bone Metastases
FEATURING
Robbe Van den Begin
- 2 views
- September 26, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: RELATIVITY-104 Study - Nivo + Relatlimab With Platinum-Doublet Chemo vs. Nivo + Platinum-Doublet Chemo as 1L Treatment for Stage IV or Recurrent NSCLC
FEATURING
Nicolas Girard
- 31 views
- September 18, 2024